ESMO Open

Published by: European Society for Medical Oncology  

People

  1. D'Angelo
    D'Angelo
  2. Rosenbaum
    Rosenbaum
  3. Tap
    Tap
  4. Antonescu
    Antonescu
  5. Chi
    Chi

Groups

  1. Department of Medicine (6)
  2. Sarcoma Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (2)
  5. Hematologic Malignancies, Division of (2)
  6. Tow Center for Developmental Oncology (TCDO) (2)
  7. Weinberg Fellows (2)
  8. Department of Pathology and Laboratory Medicine (1)
  9. Human Oncology and Pathogenesis Program (1)
Search Within
  1. "Sarcoma Service"
Formats
  1. Journal Article (5)
  2. Review (1)
Groups
  1. Department of Medicine (6)
  2. Sarcoma Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (2)
  5. Hematologic Malignancies, Division of (2)
  6. Tow Center for Developmental Oncology (TCDO) (2)

More Groups

People
  1. Evan Rosenbaum (2)
  2. Sandra D'Angelo (2)
  3. William Tap (2)
  4. Cristina Antonescu (1)
  5. Ping Chi (1)
Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (2)
Publishers
  1. European Society for Medical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: Retrospective study from the Ultra-Rare Sarcoma Working Group
    Journal Article

    Giani, C.; Denu, R. A.; Ljevar, S.; Gronchi, A.; Napolitano, A.; Rosenbaum, E.; Salawu, A.; Bajpai, J.; Connolly, E. A.; Lee, A. T. J.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
    Journal Article

    D'Angelo, S. P.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G. J.; Hassel, J. C.; Kiecker, F.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: Results from a retrospective worldwide registry
    Journal Article

    Hindi, N.; Razak, A.; Rosembaum, E.; Jonczak, E.; Hamacher, R.; Rutkowski, P.; Bhadri, V. A.; Skryd, A.; Brahmi, M.; Alshibany, A.; more...
    ESMO Open (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
    Journal Article

    Janku, F.; Bauer, S.; Shoumariyeh, K.; Jones, R. L.; Spreafico, A.; Jennings, J.; Psoinos, C.; Meade, J.; Ruiz-Soto, R.; Chi, P.
    ESMO Open (2022)

    Fulltext@MSK | Save
  • Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): Updated overall survival data after > 5 years of follow-up
    Journal Article

    D'Angelo, S. P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save
  • Epithelioid hemangioendothelioma, an ultra-rare cancer: A consensus paper from the community of experts
    Review

    Stacchiotti, S.; Miah, A. B.; Frezza, A. M.; Messiou, C.; Morosi, C.; Caraceni, A.; Antonescu, C. R.; Bajpai, J.; Baldini, E.; Bauer, S.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save

    • ESMO Open – authorized name for:

    Name ISSN / ISBN Publisher
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 20597029 The Authors
    ESMO Open 20597029 Unknown
    ESMO Open 20597029 The Pfizer, The Author(s)
    ESMO Open 2059-7029 Elsevier Inc.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 20597029 The Author(s)
    ESMO Open 2059-7029 European Society for Medical Oncology
    ESMO Open 2059-7029 European Society for Medical Oncology
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 20597029 European Society for Medical Oncology
    ESMO Open 20597029 Kura Oncology, Inc., The Author(s)
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 European Society for Medical Oncology
    ESMO Open 20597029 2022
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Group
    ESMO Open 2059-7029 BMJ Group